![]()
北京時間3月28日至30日,由美國心臟病學會(ACC)舉辦的心血管領域盛會——ACC.26學術會議將在美國新奧爾良隆重舉行。本次為期3天的會議亮點滿滿,設有7場最新突破性臨床試驗(Late-Breaking Clinical Trials)、5場特色臨床研究(Featured Clinical Research)等多場精彩會議,將公布眾多前沿臨床研究成果。其中,來自中國人民解放軍東部戰區總醫院的唐春香教授與郭翔教授、中國醫學科學院阜外醫院的康連鳴教授將分別報告其團隊在冠狀動脈疾病無創評估、人群篩查及心肌病治療領域的前沿成果,展現中國心血管臨床研究的深度與廣度。目前官網日程已發布,POCKETIN對FCR專場日程進行詳細整理,一起先睹為快!
Featured Clinical Research I
北京時間:3月29日 02:00-03:00
A Prospective Multicenter Registry to Define Coronary Vasomotor Disorders in Ischemia With Nonobstructive Coronary Arteries: Primary Results of Discover Inoca
一項前瞻性多中心注冊研究旨在明確非阻塞性冠狀動脈缺血中的冠狀動脈血管舒縮功能障礙:DISCOVER INOCA研究主要結果
Samit M. Shah
Impact of Ivabradine on Orthostatic Intolerance, Quality of Life and Heart Rate in Post-Covid Postural Orthostatic Tachycardia Syndrome: Results From the Recover-Autonomic Trial
伊伐布雷定對新冠后體位性心動過速綜合征患者直立不耐受、生活質量及心率的影響:RECOVER-AUTONOMIC試驗結果
Saibal Kar Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Sex Differences in Underlying Causes of Myocardial Infarction With No Obstructive Coronary Arteries
應用冠脈光學相干斷層掃描與心臟磁共振成像探究非阻塞性冠脈心肌梗死病因的性別差異
Harmony R. Reynolds A Sham Controlled Randomised Trial Evaluating the Safety, Acceptability and Efficacy of Autonomic Neuromodulation Using Trans-Cutaneous Vagal Sensory Stimulation in Uncontrolled Hypertensive Patients
評估經皮迷走神經感覺刺激用于未控制高血壓患者自主神經調節的安全性、可接受性與有效性:一項假刺激對照隨機試驗
Ajay K. Gupta
Featured Clinical Research II
北京時間:3月29日 03:30-04:30
Effects of Tirzepatide Compared With Dulaglutide on Expanded Cardiorenal Outcomes
替西帕肽對比度拉糖肽對擴展心腎結局的影響
Steven E. Nissen
Prevalence and Clinical Impact of Hypercortisolism in Individuals With Resistant Hypertension: Primary Results From the Momentum Study
難治性高血壓患者中皮質醇增多癥的患病率與臨床影響:MOMENTUM研究的主要結果
Deepak L. Bhatt Reliability of CAC=0 to Exclude Coronary Plaque in Diverse Global Cohorts: A Global Probability Study of Coronary Artery Disease (GPS-CAD) Analysis
CAC=0在不同種族隊列中排除冠脈斑塊的可靠性評估:全球冠狀動脈疾病概率研究(GPS-CAD)數據分析
Lohendran Baskaran
Community-to-Clinic Linkage Implementation Program to Prevent Hypertension in Barbershops
基于理發店的社區-診所聯動高血壓預防計劃實施研究
Joseph E. Ravenell
Featured Clinical Research III
北京時間:3月30日 02:15-03:15
10-year Follow-up of Clopidogrel Vs Aspirin Monotherapy in Stable Coronary Artery Disease After Percutaneous Coronary Intervention With Drug-eluting Stent
藥物洗脫支架經皮冠狀動脈介入治療后,氯吡格雷對比阿司匹林單藥治療穩定型冠狀動脈疾病的10年隨訪
Hyo-Soo Kim
Coronary CT Derived Fractional Flow Reserve-guided Management of Patients With Stable CAD: 3-year Outcomes From A Multicentre, Pragmatic, Open-label, Randomised Controlled Trial in China
冠狀動脈CT衍生的血流儲備分數指導的穩定型冠狀動脈疾病患者管理:一項中國多中心、實用性、開放標簽、隨機對照試驗的3年結果
唐春香 中國人民解放軍東部戰區總醫院 Role of Screening With Coronary Computed Tomography Angiography in Lipid Management in an Asymptomatic Chinese Population: A Community-Based, Parallel-Group, Open-Label, Randomized Clinical Trial (RESPECT2)
冠狀動脈CT血管造影篩查在無癥狀中國人群血脂管理中的作用:一項基于社區的、平行組、開放標簽、隨機臨床試驗(RESPECT2)
郭翔 中國人民解放軍東部戰區總醫院
Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure
對高風險糖尿病患者進行針對性評估以識別未確診的心力衰竭
Daniel Taylor-Sweet
Featured Clinical Research IV
北京時間:3月30日 03:45-04:45
Automated Notifications to Improve Referral and Treatment of Severe Aortic Stenosis and Mitral Regurgitation: Outcomes From the Randomized Alert Trial
自動化通知改善重度主動脈瓣狹窄和二尖瓣反流的轉診與治療:隨機ALERT試驗的結果
Wayne B. Batchelor
A Randomized Controlled Trial of a Novel Just-in-Time Adaptive Mobile Application Intervention to Reduce Sodium Intake and Blood Pressure in Patients With Hypertension
一項關于新型即時適應性移動應用程序干預以降低高血壓患者鈉攝入和血壓的隨機對照試驗
Michael Dorsch
NOTIFY-HF: A Randomised Pilot Trial of Patient-Facing Heartlogic Alerts in Heart Failure Patients
NOTIFY-HF:一項面向心力衰竭患者的HeartLogic警報的隨機試點試驗
Joseph Assad
MUTTON-HF (Medically Utilized Tailored Traditional Foods to Optimize Nutrition in Heart Failure): A Randomized Controlled Trial of an Indigenous Food is Medicine Intervention
MUTTON-HF(醫療化應用定制傳統食物以優化心力衰竭營養):一項本土食物即藥物的干預措施隨機對照試驗
Lauren A. Eberly
Featured Clinical Research V
北京時間:3月30日 6:00-7:00
Two-Year Outcomes of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation: The TRISCEND II Randomized Trial
經導管三尖瓣置換治療重度三尖瓣反流的兩年結果:TRISCEND II 隨機試驗
Vinod H. Thourani
Efficacy and Safety of BHB/HRS-1893 in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From A 12-week Phase 2 Study
BHB/HRS-1893在有癥狀的梗阻性肥厚型心肌病中的療效與安全性:一項為期12周的2期研究結果
康連鳴 中國醫學科學院阜外醫院
The Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Non-inferiority Randomized Trial
心房起搏支持在心臟再同步化治療中的作用:一項非劣效性隨機試驗
Mauro Biffi
Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI
行直接經皮冠狀動脈介入治療的STEMI患者的院前肝素給藥
Misa Fister
POCKETIN 將挑選重點研究,就已發布結果邀請專家陸續解讀
POCKETIN接受投稿,我們將為撰稿作者提供該研究的過往詳細資料,資料包括:原文、演講幻燈、官方新聞、演講視頻等素材。并根據稿件質量支付稿費。
稿件將發表在POCKETIN、心關注微信公眾號上,并發表在國際期刊《翳望》(ISSN 2709-9105)上。同時,稿件將作為供稿提供給合作單位。
投稿請聯系:zhengsisi@medicaltelescope.cn 鄭思思
如發現文內有誤請聯系我們
來源:ACC.26
![]()
特別聲明:以上內容(如有圖片或視頻亦包括在內)為自媒體平臺“網易號”用戶上傳并發布,本平臺僅提供信息存儲服務。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.